These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 24374271)
1. Bifunctional thiosialosides inhibit influenza virus. Yang Y; He Y; Li X; Dinh H; Iyer SS Bioorg Med Chem Lett; 2014 Jan; 24(2):636-43. PubMed ID: 24374271 [TBL] [Abstract][Full Text] [Related]
2. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors. Suzuki K; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Matsuoka K Bioorg Med Chem; 2012 Jan; 20(1):446-54. PubMed ID: 22100261 [TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains. Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents. Lin C; Sun C; Liu X; Zhou Y; Hussain M; Wan J; Li M; Li X; Jin R; Tu Z; Zhang J Antiviral Res; 2016 May; 129():13-20. PubMed ID: 26802557 [TBL] [Abstract][Full Text] [Related]
6. New adamantane derivatives can overcome resistance of influenza A(H1N1)pdm2009 and A(H3N2) viruses to remantadine. Shibnev VA; Garaev TM; Finogenova MP; Shevchenko ES; Burtseva EI Bull Exp Biol Med; 2012 Jun; 153(2):233-5. PubMed ID: 22816091 [TBL] [Abstract][Full Text] [Related]
7. Anti-influenza A Virus Activity of Dendrobine and Its Mechanism of Action. Li R; Liu T; Liu M; Chen F; Liu S; Yang J J Agric Food Chem; 2017 May; 65(18):3665-3674. PubMed ID: 28417634 [TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses. Kumar N; Sharma NR; Ly H; Parslow TG; Liang Y Antimicrob Agents Chemother; 2011 Dec; 55(12):5553-9. PubMed ID: 21930873 [TBL] [Abstract][Full Text] [Related]
9. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses. Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853 [TBL] [Abstract][Full Text] [Related]
10. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry. Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783 [TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase. Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390 [TBL] [Abstract][Full Text] [Related]
12. Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir. Samson M; Abed Y; Desrochers FM; Hamilton S; Luttick A; Tucker SP; Pryor MJ; Boivin G Antimicrob Agents Chemother; 2014 Sep; 58(9):5220-8. PubMed ID: 24957832 [TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses. Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776 [TBL] [Abstract][Full Text] [Related]
14. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion. Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411 [TBL] [Abstract][Full Text] [Related]
15. The epidemiology and spread of drug resistant human influenza viruses. Hurt AC Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471 [TBL] [Abstract][Full Text] [Related]
16. Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses. Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K Bioorg Med Chem; 2009 Aug; 17(15):5465-75. PubMed ID: 19589684 [TBL] [Abstract][Full Text] [Related]
17. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors. Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598 [TBL] [Abstract][Full Text] [Related]
18. Novel amides modified rupestonic acid derivatives as anti-influenza virus reagents. Li G; Obul M; Zhao JY; Liu GY; Lu W; Aisa HA Bioorg Med Chem Lett; 2019 Oct; 29(19):126605. PubMed ID: 31439378 [TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of human influenza A virus replication by chloroquine. Ooi EE; Chew JS; Loh JP; Chua RC Virol J; 2006 May; 3():39. PubMed ID: 16729896 [TBL] [Abstract][Full Text] [Related]
20. In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate. Ilyushina NA; Donnelly RP Antiviral Res; 2014 Nov; 111():112-20. PubMed ID: 25245230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]